Cargando…
Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?
There is an implied assumption that addictions to different substances vary in strength from weak (easier to stop) to strong (harder to stop), though explicit definitions are lacking. Our hypothesis is that the strength of addictions can be measured by cessation rates found with placebo or no treatm...
Autores principales: | Moore, Robert A., Aubin, Henri-Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315081/ https://www.ncbi.nlm.nih.gov/pubmed/22470287 http://dx.doi.org/10.3390/ijerph9010192 |
Ejemplares similares
-
A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
por: Rennard, Stephen, et al.
Publicado: (2012) -
Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation
por: Joksić, Gordana, et al.
Publicado: (2011) -
On clinical trials with a high placebo response rate
por: Chi, George Y.H., et al.
Publicado: (2015) -
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
por: King, David P, et al.
Publicado: (2012) -
Biological basis of tobacco addiction: Implications for smoking-cessation treatment
por: Jiloha, R. C.
Publicado: (2010)